Katarzyna Mitręga

439 total citations
46 papers, 262 citations indexed

About

Katarzyna Mitręga is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Katarzyna Mitręga has authored 46 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Katarzyna Mitręga's work include Atrial Fibrillation Management and Outcomes (22 papers), Cardiac Arrhythmias and Treatments (18 papers) and Cardiac electrophysiology and arrhythmias (15 papers). Katarzyna Mitręga is often cited by papers focused on Atrial Fibrillation Management and Outcomes (22 papers), Cardiac Arrhythmias and Treatments (18 papers) and Cardiac electrophysiology and arrhythmias (15 papers). Katarzyna Mitręga collaborates with scholars based in Poland, United Kingdom and Denmark. Katarzyna Mitręga's co-authors include Zbigniew Kalarus, Tadeusz F. Krzemiński, Witold Streb, Michał Żorniak, Tomasz Podolecki, Szymon Białka, Adam Sokal, Beata Średniawa, Radosław Lenarczyk and Grzegorz Opolski and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Katarzyna Mitręga

45 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarzyna Mitręga Poland 10 193 39 35 25 18 46 262
Günther Krumpl Austria 12 218 1.1× 65 1.7× 18 0.5× 22 0.9× 17 0.9× 40 327
Yukitoshi Ikeya Japan 7 163 0.8× 24 0.6× 13 0.4× 18 0.7× 14 0.8× 20 218
Patrizia Pepi Italy 9 144 0.7× 19 0.5× 25 0.7× 18 0.7× 11 0.6× 20 181
Amarild Cuko Italy 8 375 1.9× 38 1.0× 21 0.6× 12 0.5× 6 0.3× 20 432
Hiroya Matsumura Japan 10 237 1.2× 73 1.9× 17 0.5× 14 0.6× 19 1.1× 24 269
Isaac Aidonidis Greece 10 261 1.4× 56 1.4× 35 1.0× 14 0.6× 14 0.8× 29 311
James Allred United States 8 192 1.0× 42 1.1× 12 0.3× 10 0.4× 24 1.3× 17 281
Tadashi Ihara Japan 9 353 1.8× 60 1.5× 78 2.2× 15 0.6× 11 0.6× 18 426
CHU‐PAK LAU China 9 238 1.2× 36 0.9× 16 0.5× 42 1.7× 21 1.2× 21 311
Matthew Smelley United States 8 112 0.6× 47 1.2× 41 1.2× 70 2.8× 10 0.6× 10 209

Countries citing papers authored by Katarzyna Mitręga

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Mitręga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Mitręga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Mitręga more than expected).

Fields of papers citing papers by Katarzyna Mitręga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Mitręga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Mitręga. The network helps show where Katarzyna Mitręga may publish in the future.

Co-authorship network of co-authors of Katarzyna Mitręga

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Mitręga. A scholar is included among the top collaborators of Katarzyna Mitręga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Mitręga. Katarzyna Mitręga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitręga, Katarzyna, Beata Średniawa, Adam Sokal, et al.. (2024). Does the atrial fibrillation still increase the risk of death? Results from the NOMED study in one-year follow-up. Polskie Archiwum Medycyny Wewnętrznej. 134(3). 1 indexed citations
3.
Grodzicki, Tomasz, Łukasz Wierucki, Małgorzata Sznitowska, et al.. (2022). Prevalence, predisposing factors and strategies to reduce polypharmacy among older patients in Poland. Polskie Archiwum Medycyny Wewnętrznej. 132(12). 7 indexed citations
4.
Streb, Witold, et al.. (2021). Intracardiac ultrasound two-dimensional and three-dimensional reconstruction for navigating percutaneous left atrial appendage occlusion. Cardiology Journal. 28(6). 986–988. 1 indexed citations
5.
Streb, Witold, et al.. (2020). Rationale for cerebral protection in patients with left atrial appendage thrombus during percutaneous left atrial appendage closure: a single-center initial experience. Polskie Archiwum Medycyny Wewnętrznej. 131(2). 202–204. 1 indexed citations
6.
Streb, Witold, Katarzyna Mitręga, Tomasz Podolecki, et al.. (2019). Comparison of transesophageal and intracardiac echocardiography in guiding percutaneous left atrial appendage closure with an Amplatzer Amulet device. Advances in Interventional Cardiology. 15(4). 446–454. 9 indexed citations
7.
Streb, Witold, et al.. (2018). Two-dimensional versus three-dimensional transesophageal echocardiography in percutaneous left atrial appendage occlusion. Cardiology Journal. 26(6). 687–695. 2 indexed citations
8.
Streb, Witold, et al.. (2017). Percutaneous left atrial appendage occlusion procedures in patients with heart failure. Kardiologia Polska. 75(9). 868–876. 2 indexed citations
9.
Podolecki, Tomasz, Radosław Lenarczyk, Jacek Kowalczyk, et al.. (2017). Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology. 120(4). 517–521. 16 indexed citations
12.
Lenarczyk, Radosław, Katarzyna Mitręga, Michał Mazurek, et al.. (2016). Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot). Polskie Archiwum Medycyny Wewnętrznej. 126(3). 138–148. 13 indexed citations
13.
Sokal, Adam, Radosław Lenarczyk, Oskar Kowalski, et al.. (2016). Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population. Heart Rhythm. 13(5). 1088–1095. 9 indexed citations
14.
Cybulska, Barbara, Zbigniew Gaciong, Piotr Hoffmań, et al.. (2016). Severe hypercholesterolaemia — when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts’ group statement. Kardiologia Polska. 74(4). 394–398. 2 indexed citations
16.
Mitręga, Katarzyna, et al.. (2012). Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine. Pharmacological Research. 66(4). 300–308. 5 indexed citations
17.
Mitręga, Katarzyna, Michał Żorniak, Dariusz Lange, et al.. (2011). Beneficial effects of l-leucine and l-valine on arrhythmias, hemodynamics and myocardial morphology in rats. Pharmacological Research. 64(3). 218–225. 15 indexed citations
18.
Krzemiński, Tadeusz F., Katarzyna Mitręga, Michał Żorniak, et al.. (2010). Differential action of two prolactin isoforms on ischemia-and re-perfusion-induced arrhythmias in rats in vivo. Journal of Endocrinological Investigation. 34(3). 206–215. 4 indexed citations
19.
Żorniak, Michał, et al.. (2010). Comparison of Thiopental, Urethane, and Pentobarbital in the Study of Experimental Cardiology in Rats In Vivo. Journal of Cardiovascular Pharmacology. 56(1). 38–44. 25 indexed citations
20.
Krzemiński, Tadeusz F., et al.. (2010). Cardioprotective Effects of an Active Metabolite of Furnidipine in 2 Models of Isolated Heart and on In Vivo Ischemia–induced and Reperfusion-induced Arrhythmias in Rats. Journal of Cardiovascular Pharmacology. 57(2). 183–193. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026